Similar Papers

Paper Title
Journal
Date
Author
Voxtalisib (XL765) in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia: an open-label, phase 2 trial
...
The Lancet Haematology | VOL. 5
, et. al. ...
14 Mar 2018
Earlier Use of Zanubrutinib Monotherapy in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Is Associated with Greater Efficacy: A Pooled Analysis from 3 Studies
Wei Xu ... Judith Trotman
Blood | VOL. 136
Wei Xu, et. al.Wei Xu ... Judith Trotman
05 Nov 2020
Phase 1 Study of Bortezomib and Romidepsin in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Indolent B-Cell Lymphoma, Peripheral T-Cell Lymphoma, or Cutaneous T-Cell Lymphoma: Updated Results
Beata Holkova ... Steven Grant
Blood | VOL. 124
Beata Holkova, et. al.Beata Holkova ... Steven Grant
06 Dec 2014
Early Changes in Circulating T-Cell Immune Profiles in Patients with Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Data from the Phase 3, Double-Blind HELIOS Trial
Rajendra Damle ... Sriram Balasubramanian
Blood | VOL. 128
Rajendra Damle, et. al.Rajendra Damle ... Sriram Balasubramanian
02 Dec 2016
View more papers

More From: Blood Neoplasia

Paper Title
Journal
Date
Author
Safety Landscape of Bispecific Antibody Therapy in Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis
Rodrigo Fonseca ... Talal Hilal
Blood Neoplasia | VOL. 2
Rodrigo Fonseca, et. al.Rodrigo Fonseca ... Talal Hilal
01 Feb 2025
Real-world safety profile of therapy with ibrutinib or acalabrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
Ramsay Hafer ... Pierluigi Porcu
Blood Neoplasia | VOL. 2
Ramsay Hafer, et. al.Ramsay Hafer ... Pierluigi Porcu
01 Feb 2025
Pathogenic germline variants in a prospective multi-center cohort of patients with multiple myeloma
Julia Erin Wiedmeier-Nutor ... Rafael Fonseca
Blood Neoplasia | VOL. 2
Julia Erin Wiedmeier-Nutor, et. al.Julia Erin Wiedmeier-Nutor ... Rafael Fonseca
01 Feb 2025
Loss of p53 Impairs Death Receptor Expression and Confers Resistance to CD19 CAR T Cell Therapy in BCP-ALL
Willem P.J Cox ... Frank N Van Leeuwen
Blood Neoplasia | VOL. 2
Willem P.J Cox, et. al.Willem P.J Cox ... Frank N Van Leeuwen
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.